doi: 10.1093/rheumatology/kei056.
Towards an epidemiology of rheumatoid arthritis outcome with respect to treatment: randomized controlled trials overestimate treatment response and effectiveness
Affiliations
- PMID: 16306476
- DOI: 10.1093/rheumatology/kei056
Item in Clipboard
Towards an epidemiology of rheumatoid arthritis outcome with respect to treatment: randomized controlled trials overestimate treatment response and effectiveness
Rheumatology (Oxford).
2005 Dec.
Abstract
The results and outcomes of randomized clinical trials of leflunomide and anti-TNF therapy are much better than are seen in rheumatoid arthritis patients in the community. This appears to be an effect of the clinical trial system. The consequence of deriving effectiveness estimates from clinical trials is to overestimate the effectiveness and thereby the cost-effectiveness of rheumatoid arthritis treatments.
Similar articles
-
Modeling the 5-year cost effectiveness of treatment strategies including tumor necrosis factor-blocking agents and leflunomide for treating rheumatoid arthritis in the Netherlands.Arthritis Rheum. 2004 Dec 15;51(6):964-73. doi: 10.1002/art.20843. Arthritis Rheum. 2004. PMID: 15593319
-
Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach.Pharmacotherapy. 2011 Jan;31(1):39-51. doi: 10.1592/phco.31.1.39. Pharmacotherapy. 2011. PMID: 21182357
-
Can observational studies replace or complement experiment?J Rheumatol Suppl. 1994 Sep;41:57-61. J Rheumatol Suppl. 1994. PMID: 7799388
-
Remission in early rheumatoid arthritis.J Rheumatol. 2010 Jul;37(7):1444-53. doi: 10.3899/jrheum.091131. Epub 2010 Jun 1. J Rheumatol. 2010. PMID: 20516031 Review.
-
[B cell depletion therapy using anti-CD20 antibodies in rheumatoid arthritis].Clin Calcium. 2007 Apr;17(4):569-76. Clin Calcium. 2007. PMID: 17404487 Review. Japanese.
Cited by
-
Dose modifications of anti-TNF drugs in rheumatoid arthritis patients under real-world settings: a systematic review.Rheumatol Int. 2015 Jul;35(7):1193-210. doi: 10.1007/s00296-015-3222-4. Epub 2015 Feb 1. Rheumatol Int. 2015. PMID: 25638015
-
Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE Registry.Rheumatol Ther. 2023 Aug;10(4):1055-1072. doi: 10.1007/s40744-023-00568-8. Epub 2023 Jun 22. Rheumatol Ther. 2023. PMID: 37349636 Free PMC article.
-
The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice.Ann Rheum Dis. 2007 Nov;66(11):1473-8. doi: 10.1136/ard.2007.072447. Epub 2007 Apr 10. Ann Rheum Dis. 2007. PMID: 17426065 Free PMC article.
-
Costs of drugs for treatment of rheumatic diseases.RMD Open. 2016 Sep 12;2(2):e000259. doi: 10.1136/rmdopen-2016-000259. eCollection 2016. RMD Open. 2016. PMID: 27651923 Free PMC article.
-
[Is it possible to compare different studies on efficacy of biologicals in patients with rheumatoid arthritis? : mixed treatment comparison as a new tool for indirect comparison of clinical studies].Z Rheumatol. 2011 Aug;70(6):517-24. doi: 10.1007/s00393-011-0827-1. Z Rheumatol. 2011. PMID: 21698473 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
